Alpha DNA Investment Management’s Williams-Sonoma WSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,322
Closed -$667K 208
2022
Q3
$667K Sell
11,322
-6,758
-37% -$480K 0.55% 70
2022
Q2
$1M Buy
18,080
+1,412
+8% +$91.3K 0.85% 56
2022
Q1
$1.21M Sell
16,668
-1,872
-10% -$142K 0.85% 62
2021
Q4
$1.57M Buy
18,540
+2,554
+16% +$238K 0.99% 50
2021
Q3
$1.42M Sell
15,986
-1,268
-7% -$107K 0.96% 53
2021
Q2
$1.38M Buy
17,254
+9,282
+116% +$790K 0.94% 74
2021
Q1
$713K Sell
7,972
-6,314
-44% -$426K 0.82% 31
2020
Q4
$727K Buy
+14,286
New +$732K 0.77% 60

Other funds holding WSM

Alpha DNA Investment Management's WSM Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Williams-Sonoma (WSM) in Q4 2022, closing a stake of 11,322 shares — an estimated $667K sold.

Alpha DNA Investment Management first reported a position in WSM in Q4 2020 and held it in 8 quarters. The position peaked at $1.57M in Q4 2021. 614 funds tracked by Wall St. Rank hold WSM as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Williams-Sonoma position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11,322 Williams-Sonoma shares in Q4 2022, an estimated $667K.
  • Alpha DNA Investment Management first reported a position in Williams-Sonoma in Q4 2020 and held it in 8 quarters.
  • Alpha DNA Investment Management's Williams-Sonoma position peaked at $1.57M in Q4 2021.
  • 614 funds tracked by Wall St. Rank held Williams-Sonoma as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.